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Abstract
Background:  The prevalence of hyperuricemia has rarely been investigated in developing
countries. The purpose of the present study was to investigate the prevalence of hyperuricemia
and the association between uric acid levels and the various cardiovascula r  r i s k  f a c t o rs  i n  a
developing country with high average blood pressures (the Seychelles, Indian Ocean, population
mainly of African origin).
Methods: This cross-sectional health examination survey was based on a population random
sample from the Seychelles. It included 1011 subjects aged 25 to 64 years. Blood pressure (BP),
body mass index (BMI), waist circumference, waist-to-hip ratio, total and HDL cholesterol, serum
triglycerides and serum uric acid were measured. Data were analyzed using scatterplot smoothing
techniques and gender-specific linear regression models.
Results: The prevalence of a serum uric acid level >420 µmol/L in men was 35.2% and the
prevalence of a serum uric acid level >360 µmol/L was 8.7% in women. Serum uric acid was strongly
related to serum triglycerides in men as well as in women (r = 0.73 in men and r = 0.59 in women,
p < 0.001). Uric acid levels were also significantly associated but to a lesser degree with age, BMI,
blood pressure, alcohol and the use of antihypertensive therapy. In a regression model,
triglycerides, age, BMI, antihypertensive therapy and alcohol consumption accounted for about 50%
(R2) of the serum uric acid variations in men as well as in women.
Conclusions: This study shows that the prevalence of hyperuricemia can be high in a developing
country such as the Seychelles. Besides alcohol consumption and the use of antihypertensive
therapy, mainly diuretics, serum uric acid is markedly associated with parameters of the metabolic
syndrome, in particular serum triglycerides. Considering the growing incidence of obesity and
metabolic syndrome worldwide and the potential link between hyperuricemia and cardiovascular
complications, more emphasis should be put on the evolving prevalence of hyperuricemia in
developing countries.
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Background
The positive association between serum uric acid and car-
diovascular diseases such as stroke or ischemic heart dis-
ease has been recognized since the 1950s and has been
confirmed by numerous epidemiological studies since
then [1-7]. However, whether uric acid is an independent
risk factor for cardiovascular mortality is still disputed as
several studies have suggested that hyperuricemia is
merely associated with cardiovascular diseases because of
confounding factors such as obesity, dyslipidemia, hyper-
tension, use of diuretics and insulin resistance [8-10].
Moreover, there is still no well-established pathophysio-
logical link between hyperuricemia and the development
of cardiovascular complications.
Elevated serum uric acid levels are commonly seen in
association with glucose intolerance, hypertension and
dyslipidemia, a cluster of metabolic and hemodynamic
disorders which characterize the so-called metabolic syn-
drome [11-15]. Studies performed in healthy volunteers
as well as in subjects with asymptomatic hyperuricemia
have suggested that the link between the metabolic syn-
drome and serum uric acid is related to the ability of insu-
lin to decrease the clearance of uric acid in the renal
proximal tubule resulting in an increase in serum uric acid
levels [16]. Several population-based studies have also
examined the influence of a number of cardiovascular risk
factors or components of the metabolic syndrome on
serum uric acid levels. Thus, elevated serum uric acid lev-
els have been linked to hypertension, hyperinsulinemia,
reduced physical activity, increased body mass index,
increased alcohol consumption and decreased HDL cho-
lesterol [11,13,14,16-22].
Most studies on uric acid have been performed in selected
white populations of North America and Europe or
entirely black populations from South Africa. In 1973,
Klein et al studied a multiracial community in Evans
County, Georgia, in order to examine the frequency distri-
bution of serum uric acid and the relationship of serum
uric acid levels with known coronary risk factors [23].
They found that the prevalence of hypertension was
greater in hyperuricemic as compared to subjects without
hyperuricemia in all race-sex groups. More recently, two
studies have explored the relationship of serum uric acid
with cardiovascular risk factors in a bi-racial community
[16,17]. However, these latter investigations were con-
ducted essentially in children and young adults. The prev-
alence of hyperuricemia has rarely been investigated in
developing countries.
The purpose of the present study was to investigate the
prevalence and the clinical correlates of hyperuricemia in
a developing country, the Seychelles, a population mainly
of African origin. A population-based health examination
survey was conducted recently in this country. The study
population represents a complete sample of the general
population including elderly subjects.
Methods
The Seychelles Heart Study II
The Seychelles Heart Study II was a second survey to assess
the cardiovascular risk factors and selective cardiovascular
outcomes in the population of the Seychelles, a group of
115 islands lying in the Indian Ocean with a relatively
high cardiovascular morbidity and mortality [24]. Indeed
statistics, which are based on death certificates established
by a doctor for all fatalities in the country, indicate that
cardiovascular disease accounted for 37% of all deaths in
2003. The study was conducted between July and Decem-
ber 1994. About 65% of the population of the Seychelles
is of black descent, 10% of predominantly Caucasian and
5% of predominantly Indian or Chinese descent, the 20%
remaining being mixed. The study was designed as a cross-
section of the general population. It has been described in
detail before [24]. A simple age- and sex-stratified random
sample of the residents aged 25–64 years living on the
principal island (89% of the total population) was
included. Among the initial group of 1280 persons, 1226
were eligible and a total of 1059 participated the study, a
response rate of 86%. All participants have been submit-
ted to a detailed questionnaire and a medical examination
in the study centre between 8 a.m. and 10 a.m.
Measures and cut-off points
Smoking
Smoking habits were classified as followed: persons who
did never smoke, ex-smokers designated persons who
reported no current smoking but regular smoking in the
past, occasional smokers referred to persons reporting
non-daily consumption of cigarettes and regular smokers,
currently smoking at least one cigarette per day.
Weight and height and body mass index
Height and body weight were measured with participants
standing without shoes and heavy outer garments. Body
mass index (BMI) was calculated as weight divided by
height squared (kg/m2). Hip and waist were measured to
the nearest 1 cm.
Alcohol habits
Alcohol consumption was assessed in two stages. In the
first, persons were categorised according to frequency of
alcohol drinking: never, occasionally but less than once a
week, once or twice a week, every other day and almost
every day. Those declaring a consumption of at least one
drink per week were further questioned about their
weekly average consumption of the different alcohol bev-
erages available.BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/9
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Blood pressure
Blood pressure (BP) was measured three times consecu-
tively on the right arm with a standard sphygmomanom-
eter, the subject being in a sitting position after at least 30
minutes of rest. Values, determined as the mean of the last
two measurements, were recorded to the nearest 2 mm
Hg, and readings based on Korotkoff first and fifth base
sounds. Participants were asked if they had taken drugs for
high blood pressure within 2 weeks prior to the examina-
tion. Hypertension was defined as a diastolic BP ≥ 95 and/
or current intake of antihypertensive medication.
Diabetes
The diagnosis of diabetes mellitus was considered when
individuals reported to have been told by a doctor to have
diabetes or tested positive for glycosuria. Presence of sugar
in the urine was tested in all participants using dipsticks
(Glukotest, Boehringer, Mannheim, Germany). All per-
sons who tested positive and were unaware of having dia-
betes were invited to have glycosuria re-checked on a
second urine sample a few hours later and, if still positive,
in a urine sample collected on the next morning after an
overnight fast (the later result was considered in such
cases). This simple screening procedure was expected to
provide only approximate estimates of diabetes preva-
lence as both a few false negative and false positive cases
may be included. Yet, the prevalence of diabetes evaluated
with this approach was very close to the figure obtained
with the measurement of fasting glucose in 1994 i.e. 7.8%
in men and 4.6 % in women [25].
Biochemical analyses
On the inviting letter, no instruction on the need to be
fasting was mentioned. Nevertheless most of the partici-
pants actually reported fasting. A venous blood sample
was obtained from 8 a.m. and 2 p.m. and centrifugation
took place within 2 hours of drawing and serum was kept
frozen at -20°C. The analyses were performed at a labora-
tory in the University Policlinic, Lausanne, Switzerland
and at the Canton Institute of Haematology and Clinical
Chemistry, St. Gallen, Switzerland. Total cholesterol was
determined enzymatically using a Boehringer test kit.
HDL-cholesterol was measured similarly after precipita-
tion with magnesium phosphotungstate. Triglycerides
were analysed enzymatically using a Cobas-Mira centrifu-
gal analyser (Wako Chemicals, USA). Uric acid was meas-
ured on a standard autoanalyzer. External controls for the
laboratory determinations were regularly performed at
the Swiss-Centre for Quality Control, by comparing the
result of the analysis of a sample obtained in the request-
ing laboratory with the average of the results from all the
participating laboratories.
Statistical analysis
All statistical analyses were carried out separately by sex
using the Stata Software 6.0 (Stata Corporation, College
Station, Texas). Linear and logistic regression techniques
were used to determine the independent predictors of
serum uric acid and hyperuricemia respectively. The vari-
ous components of the metabolic syndrome, as well as the
other established risk factors of uric acid (alcohol con-
sumption, use of diuretics, etc.), were considered as
potential explanatory variables in these models. Because
data regarding the relationship of uric acid to cardiovascu-
lar disease is lacking in developing countries, ad-hoc crite-
ria for hyperuricemia were adopted in this study. Values of
uric acid above the sex-specific percentile 75 (i.e. >460
µmol/L for men and >296 µmol/L for women) were
defined as high.
For continuous variables, the linear correlation coeffi-
cients with uric acid were first calculated and tested
against zero. The statistically significant covariates were
then included in a multivariate linear regression model
and a stepwise backward selection procedure was used to
determine which covariates contributed to the variation of
uric acid independently of the others. Age, triglycerides,
body mass index and alcohol consumption were retained
in the final parsimonious regression model for both sexes.
Robust estimators of the regression coefficients, based on
the command "rreg" in the Stata software, were used
because of some very high values of acid uric in the Sey-
chelles. For categorical and binary variables, the strength
of association with high uric acid was measured using the
Mantel-Haenszel test for linear trend and the Pearson chi-
square test respectively. A multivariate logistic regression
model predicting high uric acid was developed resorting
to the same stepwise method of variable selection.
Results
The characteristics of the participants are presented in
Table 1. Smoking, alcohol consumption and high triglyc-
erides levels were more common in men than in women.
As shown in this table and in Figure 1, serum uric acid lev-
els were significantly higher in men than in women (p <
0.01). When using the commonly accepted cut-off values
for serum uric acid levels, i.e a serum uric acid >420 µmol/
L in men and >360 µmol/L in women [3], the prevalence
of hyperuricemia would be 35.1% in men and 8.7% in
women (p < 0.01). In this analysis, however, we have used
the sex-specific 75th percentile which gives a cut-off at 460
µmol/L for men and 296 µmol/L for women. Table 1 also
shows the simple correlation coefficients between serum
uric acid levels and the various cardiovascular risk factors
in the population. In both sexes, serum triglycerides and
serum uric acid levels were strongly correlated (p < 0.001).
In women, significant correlations (p < 0.01) were also
found with almost all metabolic parameters except forBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/9
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Table 1: Mean levels, standard deviations and correlations with uric acid for selected cardiovascular risk factors by sex
Men (n = 482) Women (n = 529)
Risk factor unit Mean SD Corr Mean SD Corr
Serum uric acid µmol/l 408.7 175.3 1.000 264.3 80.0 1.000
Age years 44.7 11.5 0.142 44.5 11.5 0.357
Systolic BP mmHg 139.5 23.1 0.242 132.7 24.0 0.319
Diastolic BP mmHg 90.8 14.2 0.215 85.3 13.6 0.295
Total cholesterol mmol/l 5.4 1.2 0.138 5.8 1.3 0.370
HDL-cholesterol mmol/l 1.53 0.50 -0.228 1.54 0.40 -0.152
Triglycerides mmol/l 1.48 1.17 0.734 1.16 0.68 0.528
Weight kg 70.0 12.5 0.254 68.0 15.2 0.290
Body mass index kg/m2 24.2 4.0 0.286 27.1 5.9 0.339
Waist cm 84.1 10.3 0.317 82.2 12.2 0.410
Waist-to-hip ratio 0.87 0.06 0.306 0.80 0.06 0.373
Alcohol intake ml/day 59.7 105.1 0.172 3.8 21.6 0.134
Smoking % 39.2 - - 7.3 - -
Treatment for hypertension % 9.0 - - 13.0 - -
History of diabetes % 5.0 - - 6.0 - -
SD: standard-deviation; BP: blood pressure Corr: correlation coefficient with serum uric acid
Distribution of serum uric acid by sex Figure 1
Distribution of serum uric acid by sex. White bars represent the distribution in men and black bars distribution in women. In 
men, the 25th percentile of serum uric acid was 305 µmol/L, the 50th percentile 374 µmol/L and the 75th percentile 460 µmol/L. 
The respective figures in women were : 215 µmol/L, 253 µmol/L and 296 µmol/L.
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alcohol consumption. In men, serum uric acid correlated
with blood pressure, body weight, total cholesterol, waist
and waist to hip ratio (p < 0.01).
Table 2 shows the multivariate model linear regression
model. Age, triglycerides, BMI, alcohol consumption and
a treatment for hypertension were the major determinants
of the variations in serum uric acid levels in both sexes.
Table 3 presents the proportion of persons with high uric
acid in sex-specific highest quartiles according to selected
cardiovascular risk factors. As shown in this table, all met-
abolic parameters were strongly associated with serum
uric acid levels. The effect of age was particularly promi-
nent in women and the effect of alcohol consumption was
more marked in men. Smoking had no effect on serum
uric acid levels.
Table 4 shows the odds ratio for high uric acid levels
according to different levels of age, triglycerides, waist,
alcohol consumption and treatment of hypertension. As
mentioned above, a high triglycerides level and the pres-
ence of hypertensive therapy was associated with a signif-
icant odd ratio of having an elevated serum uric acid level
in this population. When excluding all subjects on anti-
hypertensive therapy, only small changes were observed
in the values of the regression coefficients. The most sub-
stantial change was found relative to the highest category
of triglycerides in the logistic regression for men, the odd
ratio decreasing from 37.5 before exclusion to 21.3 after
exclusion. This suggests that antihypertensive therapy and
particularly diuretics play a role in the association
between a high triglyceride and a high uric acid level in
men.
Table 2: Parsimonious robust multivariate linear regression model on serum uric acid by sex.
Men (n = 482) Women (n = 529)
Explanatory variables unit Coeff SD P Coeff SD P
Age years 0.70 0.34 0.040 0.62 0.21 0.004
Triglycerides mmol/l 99.34 3.38 0.000 46.54 3.56 0.000
Body mass index (BMI) kg/m2 2.08 1.01 0.040 2.83 0.41 0.000
Alcohol intake ml/day 0.16 0.04 0.000 0.21 0.10 0.041
Treatment for hypertension 0/1 45.93 13.66 0.001 35.96 7.23 0.000
Intercept 160.0 27.73 0.000 95.18 12.94 0.000
% variation explained (R2) 0.488 0.471
Table 3: Proportion of persons with high uric acid (i.e. in sex-specific highest quartile) according to selected cardiovascular risk factors, 
by sex
Men Women
n% P n% P
Age group
25–34 115 13.9% 139 8.6%
35–44 113 24.8% 134 17.9%
45–54 130 33.1% 131 34.4%
55–64 124 26.6% 0.009 125 40.8% <0.001
Blood pressure
<130/85 mmHg 117 15.4% 223 13.0%
>130/85 mmHg 223 22.9% 209 30.6%
>160/100 mmHg 142 35.9% <0.001 97 40.2% <0.001
Treatment for hypertension
no 438 21.7% 460 20.4%
yes 44 56.8% <0.001 69 55.1% <0.001
Total cholesterol
<5.2 mmol/l 231 19.0% 197 13.2%
5.2–6.2 mmol/l 135 28.1% 165 23.0%BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/9
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>6.2 mmol/l 116 32.8% <0.001 167 40.7% <0.001
HDL-Cholesterol
>1.55 mmol/l 201 15.4% 248 20.2%
1.03–1.55 mmol/l 208 26.4% 240 25.4%
<1.03 mmol/l 73 46.6% <0.001 41 51.2% <0.001
Triglycerides
<1.0 mmol/l 199 4.5% 273 11.4%
1.0–1.7 mmol/l 157 17.8% 168 28.0%
>1.7 mmol/l 126 65.9% <0.001 88 61.4% <0.001
Body mass index
<25 288 18.1% 207 11.6%
25–30 147 32.0% 168 23.8%
>=30 43 46.5% <0.001 154 44.2% <0.001
Waist
<77 cm 124 6.5% 202 7.9%
77–88 cm 177 24.3% 152 25.0%
>88 cm 179 38.0% <0.001 171 45.6% <0.001
Regular cigarette smoking
no 293 27.3% 492 24.2%
yes 189 21.2% 0.128 37 35.1% 0.138
Alcohol consumption
0 ml/j 234 20.9% 498 24.3%
>0 ml/j 248 28.6% 0.051 31 35.5% 0.163
History of diabetes
no 458 24.0% 499 23.4%
yes 24 41.7% 0.051 30 50.0% 0.001
Total 482 24.9% 529 25.0%
P Mantel-Haenszel test for linear association
Table 4: Parsimonious multivariate logistic regression model for predicting high uric acid (i.e. in sex-specific highest quartile) by sex
Men Women
OR 95% CI P OR 95% CI P
Age group
25–34 1.00 -- -- -- 1.00 -- -- --
35–44 1.07 0.46 2.50 0.878 1.86 0.83 4.18 0.134
45–54 2.24 1.00 5.05 0.051 2.96 1.36 6.47 0.006
55–64 1.11 0.47 2.61 0.810 2.71 1.24 5.91 0.012
Treatment for hypertension
no 1.00 -- -- -- 1.00 -- -- --
yes 4.98 2.12 11.68 0.000 2.43 1.31 4.51 0.005
Triglycerides
<1.0 mmol/l 1.00 -- -- -- 1.00 -- -- --
1.0–1.7 mmol/l 3.31 1.45 7.55 0.005 2.11 1.23 3.63 0.007
>1.7 mmol/l 37.49 16.09 87.33 0.000 7.50 3.95 14.23 0.000
Table 3: Proportion of persons with high uric acid (i.e. in sex-specific highest quartile) according to selected cardiovascular risk factors, 
by sex (Continued)BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/9
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Discussion
The main observations of the present study are the follow-
ing: firstly, the prevalence of hyperuricemia is high in our
group of male Black subjects from the Seychelles. Sec-
ondly, significant relationships between serum uric and
the various components of the metabolic syndrome were
found in men as well as in women. Thirdly, a particularly
strong association was found between serum uric acid lev-
els and triglycerides. This association persisted after full
adjustment in a multiple logistic model suggesting a close
link between serum uric acid and serum triglycerides
levels.
In accordance with previous studies, we found that serum
uric acid levels are higher in men than in women,
although uric acid levels in women tend to increase above
the age of 50 [8,26,27]. These sex differences of serum uric
acid levels and the increase after the menopause in
females have been reported previously and attributed to
the influence of sexual hormones [29]. We also found that
male subjects have a higher prevalence of hyperuricemia
than women. Black men in our study had unusually ele-
vated serum uric acid levels, higher than those found in
previous studies including Black populations [16,17]. A
partial explanation for this could be the alcohol consump-
tion. Alcohol consumption is significantly associated with
elevated uric acid levels [29]. In our multivariate linear
regression model, alcohol consumption contributes sig-
nificantly to uric acid levels in men. Another important
factor may be the use of antihypertensive agents such as
diuretics which are known to increase serum uric acid lev-
els [30,31]. In the Seychelles, diuretics belong to the most
frequently prescribed first line therapy of essential hyper-
tension. Hence, it is not surprising that anti-hypertensive
therapy contributes significantly to the variations in
serum uric acid in men as well as in women. Yet the strong
association between serum uric acid and triglycerides per-
sisted even after exclusion of all subjects receiving antihy-
pertensive therapies.
Significant correlations were found between serum uric
acid and several components of the metabolic syndrome,
such as a higher BMI, waist-to-hip-ratio, blood pressure
and lower HDL-cholesterol in both men and women. Sev-
eral possible pathophysiological mechanisms have been
evoked to explain these associations including insulin
resistance [13,14], the use of diuretics [30,31] or impaired
renal function accompanying hypertension [32,33].
Indeed the kidney seems to play an important role in the
development of the metabolic syndrome [15]. Insulin-
resistant individuals secrete larger amounts of insulin in
order to maintain an adequate glucose metabolism. The
kidney which is not insulin-resistant responds to these
high insulin levels by decreasing uric acid clearance, prob-
ably linked to insulin-induced urinary sodium retention
[15]. Insulin resistance may increase blood pressure
directly via enhanced proximal tubular sodium reabsorp-
tion [34,35], or indirectly by the sympatho-adrenal sys-
tem [36]. Thereby, the kidney has been implicated as the
potential link between muscle insulin resistance and com-
pensatory hyperinsulinemia and the development of
hyperuricemia and eventually hypertension.
The most striking association found in our study is cer-
tainly the close relationship between serum triglycerides
and serum uric acid levels and hyperuricemia. These
observations were made in both sexes, with higher corre-
lation levels in Black males. Interestingly the association
was obtained even within the normal range of serum trig-
lycerides. The correlation of triglycerides with uric acid
has been found previously in several groups of patients
[11,13,16,17,37-41] including in patients with primary
gout where a strong correlation (r = 0.68, n = 44) was
found between urinary uric acid excretion and serum trig-
lycerides particularly among non-drinkers. A strong corre-
lation (r = 0.541) has even been reported in healthy
subjects [38]. This association could have been explained
by confounding factors such as the BMI or other associ-
ated variables as suggested previously. However, in our
partially corrected correlations, the high statistical signifi-
cance persisted although the coefficients were lower prob-
ably under the influence of age and BMI. In our robust
multivariate linear regression model, age combined with
BMI, triglycerides and anti-hypertensive therapy
Waist
<77 cm 1.00 -- -- -- 1.00 -- -- --
77–88 cm 2.90 1.16 7.27 0.023 2.87 1.46 5.63 0.002
>88 cm 1.96 0.78 4.90 0.152 4.24 2.18 8.23 0.000
Alcohol consumption
0 ml/day 1.00 -- -- -- 1.00 -- -- --
>0 ml/day 1.55 0.90 2.68 0.113 2.38 0.97 5.85 0.059
Table 4: Parsimonious multivariate logistic regression model for predicting high uric acid (i.e. in sex-specific highest quartile) by sex BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/9
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accounted for most of the variability of serum uric acid
levels. The mechanism for the strong association of trig-
lycerides values and serum uric acid levels are still not elu-
cidated. Although, genetic factors have been associated
with the concurrence of gout and hypertriglyceridemia
[42,43], most investigators tend to conclude that hyperu-
ricemia and hypertriglyceridemia reflects more the life-
style of the patient, as part of the metabolic syndrome,
than genetic factors.
The interpretation of the present results is confronted by
some limitations. Firstly, the data analysis was restricted
to a cross-sectional study (the Seychelles Heart Study II).
Only a prospective study could confirm the interdepend-
encies of changes in the metabolic syndrome components
and serum uric acid levels. Secondly, no serum insulin
levels were measured as an index for insulin resistance. As
insulin resistance is believed to play a major role in the
metabolic syndrome, the inclusion of this variable in our
statistical analysis would have been important. On the
other hand it is unlikely that adjustment for insulin resist-
ance could significantly influence our strongest associa-
tion of serum uric acid and triglycerides, nor let disappear
the differences found in men and women. Another limita-
tion is that the study did not include individuals aged >65
years who may be exposed to a greater cardiovascular risk.
Recent studies have shown that uric acid is also a prognos-
tic marker in elderly patients with isolated systolic hyper-
tension [7,44]. Finally the problem of over-adjustment
when dealing with highly interrelated variables as those in
the metabolic syndrome is well known.
Conclusions
In conclusion, our data show that hyperuricemia is very
frequent in a developing country. Alcohol consumption
and the use of diuretics appear to play an important role
in mediating this hyperuricemia. However, hyperuricemia
is also closely linked to the various components of the
metabolic syndrome and in particular to serum triglycer-
ides. Considering the rapidly increasing incidence of
obesity and metabolic syndrome around the World and
the potential link between hyperuricemia and coronary
heart disease or stroke, more emphasis should be put on
the evolving prevalence of hyperuricemia in developing
countries.
Our results also provide some insights on the possible
role of hyperuricemia as a risk factor in the development
of cardiovascular complications. Indeed, several studies
have found that uric acid is a prognostic marker for cardi-
ovascular mortality and stroke [1-7]. Yet several other
studies could not demonstrate a significant relationship
between serum uric acid and cardiovascular diseases [8-
10]. Experimentally, a longstanding hyperuricemia has
been found to cause renal tubulo-interstitial injury which
may lead to the development of hypertension and hence
to cardiovascular complications [45]. In humans, even
though raising serum uric acid concentrations in healthy
people does not appear to impair cardiovascular function
[46], elevated uric acid concentrations have been found to
be a powerful risk marker in heart failure patients [47] and
in elderly hypertensive patients [7,44]. The demonstra-
tion of a close relationship between serum uric acid and
parameters of the metabolic syndrome reveals another
possible link between serum uric acid and cardiovascular
morbidity and mortality.
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